29 October 2007
Oxford Immunotec completes $40M financing ... more» (PDF)
09 October 2007
Study results confirm T-SPOT®.TB is cost-effective in TB control programmes ... more» (PDF)
10 September 2007
Study results suggest the utility of T-SPOT®.TB in monitoring treatment for latent TB infection (LTBI) ... more» (PDF)
10 August 2007
Report highlights the reliability of T-SPOT®.TB following administration of the Tuberculin Skin Test ... more» (PDF)
04 May 2007
Winners celebrate Success at Martin and Audrey Wood Enterprise Awards ... more» (PDF)
19 April 2007
Study results confirm utility of T-SPOT®.TB as a rapid rule out test for tuberculosis disease ... more» (PDF)
04 April 2007
Oxford Immunotec Grants License over T-SPOT® technology to sanofi pasteur for human vaccine research ... more» (PDF)
28 March 2007
Study results confirm superior efficacy of T-SPOT®.TB over QuantiFERON and the TST in detecting TB infection in HIV patients ... more» (PDF)
05 March 2007
Study results support use of T-SPOT.TB to monitor latent TB infection ... more» (PDF)
Oxford Immunotec completes $40M financing ... more» (PDF)
09 October 2007
Study results confirm T-SPOT®.TB is cost-effective in TB control programmes ... more» (PDF)
10 September 2007
Study results suggest the utility of T-SPOT®.TB in monitoring treatment for latent TB infection (LTBI) ... more» (PDF)
10 August 2007
Report highlights the reliability of T-SPOT®.TB following administration of the Tuberculin Skin Test ... more» (PDF)
04 May 2007
Winners celebrate Success at Martin and Audrey Wood Enterprise Awards ... more» (PDF)
19 April 2007
Study results confirm utility of T-SPOT®.TB as a rapid rule out test for tuberculosis disease ... more» (PDF)
04 April 2007
Oxford Immunotec Grants License over T-SPOT® technology to sanofi pasteur for human vaccine research ... more» (PDF)
28 March 2007
Study results confirm superior efficacy of T-SPOT®.TB over QuantiFERON and the TST in detecting TB infection in HIV patients ... more» (PDF)
05 March 2007
Study results support use of T-SPOT.TB to monitor latent TB infection ... more» (PDF)
